Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: Possible involvement of the COX-2 metabolite prostamide E 2

Biochemical Journal

Volumn 409, Issue 3, 2008, Pages 761-770

  Correa, Fernando ^a   Docagne, Fabian ^a   Clemente, Diego ^a   Mestre, Leyre ^a   Becker, Christoph ^b   Guaza, Carmen ^a  

^a INSTITUTO CAJAL   (Spain)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Anandamide (AEA); Endocannabinoid; Interleukin 12 (IL 12) p40 subunit; Microglia; Multiple sclerosis (MS); Prostamide E2

Indexed keywords

AMIDES; GAMMA RAYS; MACROPHAGES; METABOLITES;

ANANDAMIDE (AEA); ENDOCANNABINOID; INTERLEUKIN-12 (IL-12) P40 SUBUNIT; MICROGLIA; MULTIPLE SCLEROSIS (MS);

ENZYME INHIBITION;

ANANDAMIDE; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; PROTEIN P19; PROTEIN P35; PROTEIN P40; VANILLOID RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE CONTROL; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARACHIDONIC ACIDS; CELLS, CULTURED; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION; INTERFERON TYPE II; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICROGLIA; MOLECULAR SEQUENCE DATA; POLYUNSATURATED ALKAMIDES; PROMOTER REGIONS (GENETICS); PROTEIN SUBUNITS; RECEPTORS, CANNABINOID; SIGNAL TRANSDUCTION;

EID: 38949143238     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20071329     Document Type: Article

References (41)

1. Lambert, D. M. and Fowler, C. J. (2005) The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. J. Med. Chem. 48, 5059-5087
2. Klein, T. W. (2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5, 400-411
3. Aloisi, F. (2001) Immune function of microglia. Glia 36, 165-179
4. Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W. and Layward, L. (2000) Cannabinoids control spasticity and tremor in a multiple sclerosis model. Nature 404, 84-87
5. Arévalo-Martín, A., Vela, J. M., Molina-Holgado, E., Borrell, J. and Guaza, C. (2003) Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci. 23, 2511-2516
6. Croxford, J. L. and Miller, S. D. (2003) Immunoregulation of a viral Model of Multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212. J. Clin. Invest. 111, 1231-1240
7. Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Makriyannis, A., Khanolkar, A., Layward, L., Fezza, F., Bisogno, T. and Di Marzo, V. (2001) Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J. 15, 300-302
8. Ortega-Gutiérrez, S., Molina-Holgado, E., Arévalo- Martín, A., Correa, F., Viso, A., López-Rodríguez, M. L., Di Marzo, V. and Guaza, C. (2005) Activation of the endocannabinoid system as a therapeutic approach in a murine model of multiple sclerosis. FASEB J. 19, 1338-1340
9. Mestre, L., Correa, F., Arévalo-Martín, A., Molina-Holgado, E., Valenti, M., Ortar, G., Di Marzo, V. and Guaza, C. (2005) Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis. J. Neurochem. 92, 1327-1339
10. Trinchieri, G. (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133-146
11. Li, J., Gran, B., Zhang, G. X., Ventura, E. S., Siglienti, I., Rostami, A. and Kamoun, M. (2003) Differential expression and regulation of IL-23 and IL-12 subunits and receptors in adult mouse microglia. J. Neurol. Sci. 215, 95-103
12. Belladonna, M. L., Renauld, J. C., Bianchi, R., Vacca, C., Fallarino, F., Orabona, C., Fioretti, M. C., Grohmann, U. and Puccetti, P. (2002) IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol. 168, 5448-5454
13. Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A. and Weiner, H. L. (1997) Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc. Natl. Acad. Sci. U.S.A. 94, 599-603
14. Lu, T., Newton, C., Perkins, I., Friedman, H. and Klein, T. W. (2006) Role of cannabinoid receptors on Δ9 tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow derived dendritic cells infected with Legionella pneumophila. Eur. J. Pharmacol. 532, 170-177
15. Matias, I., Pochard, P., Orlando, P., Salzet, M., Pestel, J. and Di Marzo, V. (2002) Presence and regulation of the endocannabinoid system in human dendritic cells. Eur. J. Biochem. 269, 3771-3778
16. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, C., Schwartz, J. C. and Piomelli, D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691
17. Walter, L., Franklin, A., Witting, A., Moller, T. and Stella, N. (2002) Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem. 277, 20869-20876
18. Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipathikon, K., Pfister, S. L., Campbell, W. B. and Hillard, C. J. (2004) Cultured rat microglial synthetize the endocannabinoid 2-arachydonylglycerol, which increases proliferation via a CB2 receptor-mediated mechanism. Mol. Pharmacol. 65, 999-1007
19. Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R. and Ullrich, O. (2006) The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49, 67-79
20. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A. and Gilula, N. B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87
21. 2 ethanolamide. J. Pharmacol. Exp. Ther. 301, 900-907
22. Molina-Holgado, E., Vela, J. M., Arévalo-Martín, A., Almazán, G., Molina-Holgado, F., Borrell, J. and Guaza, C. (2002) Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J. Neurosci. 22, 9742-9753
23. Plevy, S. E., Gemberling, J. H., Hsu, S., Dorner, A. J. and Smale, S. T. (1997) Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17, 4572-4588
24. 2. J. Immunol. 167, 2608-2618
25. Luo, Q., Ma, X., Wahl, S. M., Bieker, J. J., Crossley, M. and Montaner, L. J. (2004) Activation and repression of interleukin-12 p40 transcription by erythroid kruppel-like factor in macrophages. J. Biol. Chem. 279, 18451-18456
26. Carlisle, S. J., Marciano-Cabral, F., Stabb, A., Ludwick, C. and Cabral, C. A. (2002) Differential expression of the CB2 cannabinoid receptor by rodent macrophage-like cells in relation to cell activation. Int. Immunopharmacol. 2,69-82
27. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D. and Hogestatt, E. D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452-457
28. Matias, I., Chen, J., De Petrocellis, L., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H., Shi, L., Protzman, C. E., Li, C. et al. (2004) Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism. J. Pharmacol. Exp. Ther. 309, 745-757
29. Molina-Holgado, F., Molina-Holgado, E., Guaza, C. and Rothwell, N. J. (2002) Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte cultures. J. Neurosci. Res. 81, 1242-1252
30. Ortega-Gutiérrez, S., Molina-Holgado, E. and Guaza, C. (2005) Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia 52, 163-168
31. Fachinetti, F., Del Giudice, G., Furegato, S., Passarotto, M. and Leon, M. (2003) Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide. Glia 41, 161-168
32. Nicoletti, F., Patti, F., Cocuzza, C., Zaccone, P., Nicoletti, A., Di Marco, R. and Reggio, A. (1996) Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis. J. Neuroimmunol. 70, 87-90
33. 't Hart, B. A., Brok, H. P., Remargue, E., Benson, J., Treacy, G., Amor, S., Hintzen, R. Q., Laman, J. D., Bauer, J. and Blezer, E. L. (2005) Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody. J. Immunol. 175, 4761-4768
34. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T. et al. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748
35. Fowler, C. J. (2007) The contribution of cyclooxygenase-2 to endocannabinoid metabolism and action. Br. J. Pharmacol. 152, 594-601
36. Di Marzo, V., De Petrocellis, L., Fezza, F., Ligresti, A. and Bisogno, T. (2002) Anandamide receptors. Prostaglandins Leukot. Essent. Fatty Acids 66, 377-391
37. Rockwell, C. E. and Kaminski, N. E. (2004) A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes. J. Pharmacol. Exp. Ther. 311, 683-690
38. Bouaboula, M., Hilairet, S., Marchand, J., Fajas, L., Le Fur, G. and Casellas, P. (2005) Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur. J. Pharmacol. 517, 174-181
39. Snider, N. T., Kornilov, A. M., Kent, U. M. and Hollenberg, P. F. (2007) Anandamide metabolism by human liver and kidney microsomal cytochrome p450 enzymes to form hydroxyeicosatetraenoic and epoxyeicosatrienoic acid ethanolamides. J Pharmacol. Exp. Ther. 321, 590-597
40. Benito, C., Romero, J. P., Tolón, R. M., Clemente, D., Docagne, F., Hillard, C. J., Guaza, C. and Romero, J. (2007) Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plague cell subtypes in human multiple sclerosis. J. Neurosci. 27, 23396-23402
41. Weber, A., Ni, J., Ling, K. H., Acheampoung, A., Tang-Lin, D. D., Burk, R. R., Cravatt, B. and Woodward, D. (2004) Formation of prostamides from anandamide in FAAH knockout mice analysing by HPLC with tandem mass spectrometry. J. Lipid. Res. 45, 757-763